All participants were 18 years or older, planned to initiate HCV antiviral treatment, and provided signed informed consent documents to participate in a single-center, open-label study (ClinicalTrials.gov Identifier: NCT02734173), which was approved by The Ottawa Health Science Network Research Ethics Board (REB 2015-0305)
It is estimated to affect approximately 9.4% of the world population (171, 172)
Kylie Jenner denied using Ozempic Kylie Jenner is back to her pre-pregnancy weight, but said she's faced scrutiny for her changing body
Incidence is accelerating fastest across urbanizing Asia-Pacific economies, where lifestyle changes and aging populations converge
This period of caution ensures uninterrupted healing and optimal tissue recovery
At the time you kick off your weight loss expedition with Zepbound (tirzepatide), starting with the recommended initial dose of 2.5 mg is vital